IMKTA (IMKTA)

$1.7B
Market Cap
18.0
P/E Ratio
0.70
Beta
0.74%
Dividend Yield
Piotroski 7/9Altman Z 4.5 SafeBeneish M -2.22 Flag (> −2.22)ROIC−WACC -3.5%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 4.5 (above 3.0 safe zone threshold). Beneish M-Score of -2.22 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of IMKTA reveal a capital allocation challenge where the return on invested capital stands at 4.5%, falling significantly short of the estimated weighted average cost of capital of 8.0%. This negative spread of -3.5% indicates that current operations are destroying shareholder value, suggesting management must either improve operational efficiency or deleverage to restore economic viability. Despite this drag on absolute returns, the DuPont components point toward a margin-constrained model rather than one driven by turnover or leverage; specifically, net margins compress at 1.6%, while gross margins hold steady near 24%. Financial stability metrics present a mixed signal: the company maintains a robust Altman Z-Score of 4.5, implying low bankruptcy risk and strong liquidity, yet its Piotroski F-Score of 7/9 suggests underlying fundamental deterioration is not severe enough to trigger distress signals immediately.

Valuation multiples currently sit at 18.0x earnings, which requires contextualization against historical norms and sector peers to determine if the market has overcorrected or remains complacent regarding future growth prospects. A discounted cash flow analysis anchors fair value at $23 per share; however, this intrinsic valuation assumes a specific trajectory of revenue recovery, given that year-over-year sales contracted by 5.4%. The divergence between the current trading price and the DCF-derived target implies significant uncertainty in projected cash flows, as the model must reconcile declining top-line growth with the necessity to generate returns exceeding the cost of capital to justify existing valuations.

The Beneish M-Score of -2.22 further supports the integrity of reported earnings by indicating a low probability of manipulation, reinforcing that the negative ROIC-WACC spread reflects genuine operational headwinds rather than accounting distortions. Collectively, these data points suggest an investment case heavily dependent on whether management can pivot to positive capital returns before the market fully reprices the asset based on persistent underperformance relative to its cost of funds.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%8%10%
2%$31$19$13
3%$42$23$15
4%$63$29$17

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $23 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.22
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

23.9%
Gross Margin
1.6%
Net Margin
4.5%
ROIC
8.0%
WACC
ROIC − WACC Spread: -3.5%— Negative spread.
-5.4%
Revenue Growth (YoY)
-20.8%
Earnings Growth (YoY)
39.6M
Free Cash Flow
31%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.59x
Debt / Equity
3.22x
Current Ratio
6.6x
Interest Coverage
0.5x
Net Debt / EBITDA
2.14%
FCF Yield
252.5M
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

19.2
Forward P/E
PEG Ratio
1.05
Price/Book
133355
Avg Volume
$90.73
52W High
$59.09
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$20M
Tracked Passive Exposure
4
ETFs Holding IMKTA
0.19%
Avg Weight in ETFs
$11B
Total ETF AUM

When investors buy or sell ETFs like XRT or VFVA, the fund manager is mechanically forced to buy or sell IMKTA shares regardless of IMKTA's individual fundamentals. We estimate $20M of passive capital is structurally linked to IMKTA through 4 tracked ETFs. Passive flows have a limited but growing influence on IMKTA's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in IMKTA to visualize passive redemption contagion across ETFs and collateral stocks.

IMKTA Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
IMKTAEpicenterVDCETFVFVAETFVFQYETFWMTLow RiskCOSTLow RiskPGLow RiskKOLow RiskPEPLow Risk
IMKTA Price Drop (%)0

If IMKTA (IMKTA) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Walmart Inc. (WMT) as the most exposed collateral stock, sharing 2 ETFs with IMKTA. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

IMKTA Ownership Dynamics

Ticker
IMKTA

ETFs with Highest IMKTA Exposure

Float lock-up computed from 4 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

IMKTA Capital Efficiency

How efficiently does IMKTA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$40M
EBITDA
$253M
FCF Conversion
16%
Reinvestment Rate
84%
16% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.5%
ROIC − WACC Spread
-3.5%

IMKTA converts 16% of its EBITDA into free cash flow, a low conversion rate suggesting heavy reinvestment. This may indicate a growth phase (building capacity) or structural capital intensity. The 84% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-3.5%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-131,336$84.49$112,878.64
2026-05-071,333$88.40$117,837.2
2026-05-045$91.31$456.55
2026-04-304$89.04$356.16
2026-04-282$90.03$180.06
2026-04-07140$92.76$12,986.4
2026-04-021$90.21$90.21
2026-03-3161$90.03$5,491.83
2026-03-266$86.57$519.42
2026-03-235$83.56$417.8
2026-03-17155$87.00$13,485
2026-03-122,909$85.18$247,788.62
2026-03-051$85.87$85.87
2026-02-253,323$88.85$295,248.55
2026-02-241,006$87.44$87,964.64
2026-02-231,098$87.35$95,910.3
2026-02-20432$86.93$37,553.76
2026-02-0612,545$84.33$1.1M
2026-02-05645$83.28$53,715.6
2026-02-04431$80.77$34,811.87
2026-01-1564$69.66$4,458.24
2026-01-13125$70.62$8,827.5
2026-01-05523$69.67$36,437.41
2025-12-231,729$71.41$123,467.89
2025-11-24165$75.92$12,526.8
2025-11-1017$74.03$1,258.51

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare IMKTA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.